[HTML][HTML] Two-year, randomized, controlled trial of belimumab in lupus nephritis

…, G Contreras, Z Amoura, X Yu, CC Mok… - … England Journal of …, 2020 - Mass Medical Soc
Background In adults with active lupus nephritis, the efficacy and safety of intravenous
belimumab as compared with placebo, when added to standard therapy (mycophenolate mofetil …

[HTML][HTML] Genome-Wide Association Study in Asian Populations Identifies Variants in ETS1 and WDFY4 Associated with Systemic Lupus Erythematosus

…, CC Mok, TM Chan, RWS Wong, KW Lee, MY Mok… - PLoS …, 2010 - journals.plos.org
Systemic lupus erythematosus is a complex and potentially fatal autoimmune disease,
characterized by autoantibody production and multi-organ damage. By a genome-wide …

Systematic review of the epidemiology of systemic lupus erythematosus in the Asia‐Pacific region: prevalence, incidence, clinical features, and mortality

…, SC Bae, W Louthrenoo, CC Mok… - Arthritis care & …, 2012 - Wiley Online Library
Objective Systemic lupus erythematosus (SLE), a chronic multisystem autoimmune disease
with a wide spectrum of manifestations, shows considerable variation across the globe, …

Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy

C Chiu Mok, C Sing Lau… - Arthritis & Rheumatism …, 1998 - Wiley Online Library
Objective To determine the incidence of ovarian failure after cyclophosphamide (CYC)
treatment for systemic lupus erythematosus (SLE) and to identify the risk factors for this …

[HTML][HTML] Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups

…, Y Tang, Y Chen, Q Song, B Ban, CC Mok… - Nature …, 2021 - nature.com
Systemic lupus erythematosus (SLE), a worldwide autoimmune disease with high heritability,
shows differences in prevalence, severity and age of onset among different ancestral …

Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups

CC Mok, SSK Tang, CH To, M Petri - Arthritis & Rheumatism, 2005 - Wiley Online Library
Objective To compare the incidence and risk factors for thromboembolic events in systemic
lupus erythematosus (SLE) patients of different ethnic backgrounds. Methods SLE patients …

[HTML][HTML] Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies …

…, S Maruyama, JM Mejía-Vilet, MJ Moeller, CC Mok… - Kidney international, 2019 - Elsevier
The Kidney Disease: Improving Global Outcomes (KDIGO) initiative organized a Controversies
Conference on glomerular diseases in November 2017. The conference focused on the …

[HTML][HTML] Biomarkers for lupus nephritis: a critical appraisal

CC Mok - BioMed Research International, 2010 - hindawi.com
… Correspondence should be addressed to Chi Chiu Mok, ccmok2005@yahoo.com …
Copyright © 2010 Chi Chiu Mok. This is an open access article distributed under the Creative …

Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case–control study

CC Mok, LY Ho, LS Fong, CH To - Annals of the rheumatic diseases, 2013 - ard.bmj.com
Chi Chiu Mok, … Chi Hung To … Correspondence to Dr Chi Chiu Mok, Department of
Medicine, Tuen Mun and Pok Oi Hospital, New Territories, Hong Kong, SAR China; ccmok2005{at}…

[PDF][PDF] Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in …

…, F Zhou, Q Diao, NKC Tse, H Xie, CC Mok… - The American Journal of …, 2013 - cell.com
Systemic lupus erythematosus (SLE) is a prototype autoimmune disease with a strong genetic
involvement and ethnic differences. Susceptibility genes identified so far only explain a …